Rheumatoid Arthritis

A fully automated assay panel for aiding the diagnosis of Rheumatoid Arthritis through quality and efficiency immunoassays

Rheumatoid arthritis (RA) is a chronic, progressive, autoimmune inflammatory polyarthritis affecting the synovial joints. RA is one of the most widespread autoimmune disorders (1-2% of the European population) and in the majority of cases its clinical evolution leads to serious limitation of joint function and grave invalidity; early diagnosis of RA therefore has important clinical implications, since therapy begun in the early stages of the disease has been shown to be effective in limiting or reducing the progression of the lesions and in improving patients’ quality of life^1,2.

Our Rheumatoid Arthritis panel aids laboratories in the diagnosis and monitoring of this disease through enhanced quality and workflow efficacy immunoassays:

Rheumatoid Factor
Anti-CCP IgG

Diagnosis of RA is today typically performed by a combined assessment of both analytes to increase the diagnostic and prognostic predictive value^3,4.